From the Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
J Invasive Cardiol. 2024 Apr;36(4). doi: 10.25270/jic/23.00281.
Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with high radiation doses. In this manuscript, we examined the contemporary trends and determinants of radiation dose in the PROGRESS CTO (Prospective Global Registry for the Study of CTO Intervention; Clinicaltrials.gov identifier: NCT02061436) registry. Radiation dose during CTO PCI did not change significantly since 2020, highlighting the need for innovation and operator education to further maintain radiation safety.
慢性完全闭塞（CTO）经皮冠状动脉介入治疗（PCI）与高剂量辐射有关。在本研究中，我们检查了 PROGRESS CTO（前瞻性全球 CTO 干预研究注册；Clinicaltrials.gov 标识符：NCT02061436）注册研究中 CTO PCI 期间辐射剂量的当代趋势和决定因素。自 2020 年以来，CTO PCI 期间的辐射剂量没有明显变化，这突出表明需要创新和操作人员教育，以进一步保持辐射安全。
